Corrigendum to “Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial” [Eur J Cancer 198 (2024) 113475]

The authors regret to advise of an error in Fig. 3A. By error, the survival curves shown were identical as in Fig. 3C. The corrected Fig. 3A is shown here:.

Source: European Journal of Cancer - April 23, 2024 Category: Cancer & Oncology Authors: Emilie Le Rhun, Thierry Gorlia, J örg Felsberg, Joost Jongen, Claude-Alain Maurage, François Ducray, Dorothee Gramatzki, Peter Hau, Olivier L. Chinot, Matthias Preusser, Stephanie Cartalat, Patrick Roth, Martin van den Bent, Julia Furtner, Maike Collien Tags: Corrigendum Source Type: research